In summary, this study shows that HPM, a traditional Chinese therapy, can block the abnormal activation of the NLRP3 inflammasome by inhibiting the P2X7R-Pannexin-1 signaling pathway, thereby reducing the release of the downstream inflammatory cytokine IL-1β and ultimately suppressing colonic inflammation in CD rats. Here, PANX1 is linked to Cowden disease.